Alto Neuroscience, Inc. (ANRO) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$51.77M | -9.2% |
| 2024 | -$47.42M | -41.8% |
| 2023 | -$33.45M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$51.77M | -9.2% |
| 2024 | -$47.42M | -41.8% |
| 2023 | -$33.45M | — |